OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Albumin in decompensated cirrhosis: new concepts and perspectives
Mauro Bernardi, Paolo Angeli, J. J. Clariá, et al.
Gut (2020) Vol. 69, Iss. 6, pp. 1127-1138
Open Access | Times Cited: 270

Showing 26-50 of 270 citing articles:

Albumin internalizes and inhibits endosomal TLR signaling in leukocytes from patients with decompensated cirrhosis
Mireia Casulleras, Roger Flores‐Costa, Marta Duran‐Güell, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 566
Closed Access | Times Cited: 61

Changes in the epidemiology and management of bacterial infections in cirrhosis
Salvatore Piano, Marta Tonon, Paolo Angeli
Clinical and Molecular Hepatology (2021) Vol. 27, Iss. 3, pp. 437-445
Open Access | Times Cited: 50

The search for disease-modifying agents in decompensated cirrhosis: From drug repurposing to drug discovery
Paolo Caraceni, Juan G. Abraldeṣ, Pere Ginès, et al.
Journal of Hepatology (2021) Vol. 75, pp. S118-S134
Open Access | Times Cited: 45

Untargeted lipidomics uncovers lipid signatures that distinguish severe from moderate forms of acutely decompensated cirrhosis
J. J. Clariá, Anna Curto, Richard Moreau, et al.
Journal of Hepatology (2021) Vol. 75, Iss. 5, pp. 1116-1127
Open Access | Times Cited: 41

Management of hepatorenal syndrome in liver cirrhosis: a recent update
Chinmay Bera, Florence Wong
Therapeutic Advances in Gastroenterology (2022) Vol. 15
Open Access | Times Cited: 36

Mesenchymal stromal cells: promising treatment for liver cirrhosis
Lichao Yao, Xue Hu, Kai Dai, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 32

Albumin administration in internal medicine: A journey between effectiveness and futility
Enrico Pompili, Giacomo Zaccherini, Maurizio Baldassarre, et al.
European Journal of Internal Medicine (2023) Vol. 117, pp. 28-37
Open Access | Times Cited: 21

Reverse-QTY code design of active human serum albumin self-assembled amphiphilic nanoparticles for effective anti-tumor drug doxorubicin release in mice
Run Meng, Shilei Hao, Changfa Sun, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 21
Open Access | Times Cited: 20

Pathophysiology of Hepatorenal Syndrome – Acute Kidney Injury
Danielle Adebayo, Florence Wong
Clinical Gastroenterology and Hepatology (2023) Vol. 21, Iss. 10, pp. S1-S10
Open Access | Times Cited: 16

Role of albumin infusion in cirrhosis-associated complications
Mohamed A. Heybe, Kosha J. Mehta
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6

Phases of fluid management and the roles of human albumin solution in perioperative and critically ill patients
Christian J. Wiedermann
Current Medical Research and Opinion (2020) Vol. 36, Iss. 12, pp. 1961-1973
Open Access | Times Cited: 48

Early Prediction of Disease Progression in Patients with Severe COVID-19 Using C-Reactive Protein to Albumin Ratio
Yi Li, Haitao Li, Chao Song, et al.
Disease Markers (2021) Vol. 2021, pp. 1-11
Open Access | Times Cited: 36

Bile Acids, Liver Cirrhosis, and Extrahepatic Vascular Dysfunction
Tilman Sauerbruch, Martin Hennenberg, Jonel Trebicka, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 33

Emerging Therapeutic Targets for Portal Hypertension
Éric Felli, Yelidousi Nulan, Sonia Selicean, et al.
Current Hepatology Reports (2023) Vol. 22, Iss. 1, pp. 51-66
Open Access | Times Cited: 15

Elevated lactate/albumin ratio as a novel predictor of in-hospital mortality in hospitalized cirrhotics
Itamar Krispin, Mahmud Mahamid, Eran Goldin, et al.
Annals of Hepatology (2023) Vol. 28, Iss. 3, pp. 100897-100897
Open Access | Times Cited: 13

Managing cirrhosis with limited resources: perspectives from sub-Saharan Africa
Mark Sonderup, Patrick S. Kamath, Yaw Asante Awuku, et al.
˜The œLancet. Gastroenterology & hepatology (2024) Vol. 9, Iss. 2, pp. 170-184
Closed Access | Times Cited: 5

Association between lactate-to-albumin ratio and all-cause mortality in cirrhosis patients: Analysis of the MIMIC-IV database
Yusong Ye, Shu Huang, Xiaohong Wang, et al.
Medicina Intensiva (English Edition) (2025), pp. 502145-502145
Closed Access

The prognostic nutritional index is an effective prognostic and nutritional status indicator for cirrhosis
Ao Zhang, Xi Chen, Weifang Zhu, et al.
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access

Effect of High Protein BCAA-Enriched Oral Nutrition Supplement (ONS) on Malnutrition in Indian Chronic Liver Disease (CLD) Patients: PROTON Study
Rachana Bhoite, Chandan Kumar Kedarisetty, Nikhileswar Yandamuri, et al.
Food and Nutrition Sciences (2025) Vol. 16, Iss. 03, pp. 255-268
Open Access

Decompensated Cirrhosis
Mauro Bernardi, Giacomo Zaccherini
(2025), pp. 583-611
Closed Access

Management of Ascites: AJR Expert Panel Narrative Review
Joshua Cornman‐Homonoff, Brett E. Fortune, K. Kolli, et al.
American Journal of Roentgenology (2025)
Closed Access

Scroll to top